The cell biology of bone metabolism

Journal of Clinical Pathology

Volumn 61, Issue 5, 2008, Pages 577-587

  Datta, H K ^a   Ng, W F ^a   Walker, J A ^b   Tuck, S P ^c   Varanasi, S S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX2;

B LYMPHOCYTE; BONE CELL; BONE GROWTH; BONE METABOLISM; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CELL ACTIVITY; CELL DIFFERENTIATION; CELL TYPE; CYTOLOGY; ENERGY METABOLISM; HUMAN; IMMUNE SYSTEM; MECHANORECEPTOR; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; REVIEW;

BONE AND BONES; BONE REMODELING; CELL DIFFERENTIATION; ENERGY METABOLISM; HUMANS; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 43549083018     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.048868     Document Type: Review

References (169)

1. Tamama K, Fan VH, Griffith LGH, et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:686-95.
2. Bonyadi M, Waldman SD, Lui D, et al. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly- 6A null mice. Proc Natl Acad Sci USA 2003;100:5840-5.
3. Yang XB, Roach HI, Clarke NMP, et al. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001;29:523-31.
4. Tare RS, Oreffo ROC, Clarke NMP, et al. Pleiotrophin/osteoblast-stimulating factor 1: dissecting its diverse functions in bone formation. J Bone Miner Res 2002;17:2009-20.
5. Harada H, Tagashira S, Fujiwara M, et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999;274:6972-8.
6. Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996;382:638-42.
7. Stanford University. The Wnt homepage. http://www.stanford.edu/ ∼musse/wntwindow.html.
8. Zeng X, Tamai K, Doble B, et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005;438:873-7.
9. Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998;280:596-9.
10. Tamai K, Semenov M, Kato Y, et al. LDL-receptor- relatedproteins in Wnt signal transduction. Nature 2000;407:530-5.
11. Pinson KI, Brennen J, Monkley S, et al. An LDL-receptor-related protein mediates Wnt signaling in mice. Nature 2000;407:535-8.
12. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
13. Brault V, Moore R, Kutsch S, et al. Inactivation of the b-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001;128:1253-64.
14. Day TF, Guo X, Garrett-Beal L, et al. Wnt/bcatenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005;8:739-50.
15. Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
16. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755-64.
17. Otto F, Thornell AP, Crompton T, et al. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-71.
18. Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 2002;157:303-14.
19. Kundu M, Javed A, Jeon JP et al. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 2002;32:639-44.
20. Yoshida CA, Furuichi T, Fujita T, et al. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 2002;32:633-8.
21. Miller J, Horner A, Stacy T, et al. The core-binding factor beta subunit is required for bone formation and hematopoetic maturation. Nat Genet 2002;32:645-9.
22. Wehrli M, Dougan ST, Caldwell K, et al. Arrow encodes an LDL-receptorrelated protein essential for Wingless signalling. Nature 2000;407:527-30.
23. Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001;107:513-23.
24. Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor related protein 5. N Engl J Med 2002;346:1513-21.
25. Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 2002;70:11-9.
26. Hill TP, Spater D, Taketo MM, et al. Canonical Wnt/b-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005;8:727-38.
27. Hu H, Hilton MJ, Tu X, et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005;132:49-60.
28. Krupnik VE, Sharp JD, Jiang C, et al. Functional and structural diversity of the human Dickkopf gene family. Gene 1999;238:301-13.
29. Tian E, Zhan F, Walker R, et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003;349:2483-94.
30. Li X, Liu P, Liu W, et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 2005;37:945-52.
31. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-63.
32. Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 2003;302:179-83.
33. Hoang B, Moos M Jr, Vukicevic S, et al. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J Biol Chem 1996;271:26131-7.
34. Yang-Snyder J, Miller JR, Brown JD, et al. A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol 1996;6:1302-6.
35. Bodine PV, Billiard J, Moran RA, et al. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J Cell Biochem 2005;96:1212-30.
36. Mao B, Wu W, Davidson G, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002;417:664-7.
37. Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 2003;302:179-83.
38. Balemans W, Ebeling M, Patel N, et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001;10:537-43
39. Balemans W, Patel N, Ebeling M, et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 2002;39:91-7
40. Staehling-Hampton K, Proll S, Paeper BW, et al. A 52-kb deletion in the SOST-MEOX1 intergenic regionon 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet 2002;110:144-52.
41. Semenov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem 2005;280:26770-5.
42. Brunkow ME, Gardner JC, Van Ness J, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot containing protein. Am J Hum Genet 2001;68:577-89.
43. Ellies DL, Viviano B, McCarthy J, et al. Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res 2006;21:1738-49.
44. Semenov MV, He X. LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST. J Biol Chem 2006;281:38276-84.
45. Poole KE, van Bezooijen RL, Loveridge N, et al. Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005;19:1842-4.
46. Siegfried E, Chou TB, Perrimon N. Wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. Cell 1992;71:1167-79.
47. Rubinfeld B, Albert I, Porfiri E, et al. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996;272:1023-6.
48. Siegfried E, Wilder EL, Perrimon N. Components of wingless signalling in Drosophila. Nature 1994;367:76-80.
49. Noordermeer J, Klingensmith J, Perrimon N, et al. Dishevelled and armadillo act in the wingless signalling pathway in Drosophila. Nature 1994;367:80-3.
50. Behrens J, Jerchow BA, Wurtele M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998;280:596-9.
51. Jiang J, Struhl G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 1998;391:493-6.
52. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-34.
53. Nakashima K, Yanagisawa M, Arakawa H, et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 1999;284:479-82.
54. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000;14:627-44.
55. Massagué J, Wotton D. Transcriptional control by the TGF-beta/Smad signalling system. EMBO J 2000;19:1745-54.
56. Lee MH, Kim YJ, Kim HJ, et al. BMP-2-induced Runx2 expression is mediated by D1x5, and TGF-beta1 opposes the BMP-2-induced osteoblast differentiation by suppression of D1x5 expression. J Biol Chem 2003;278:34387-94.
57. Lee MH, Kwon TG, Park HS, et al. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003;309:689-94.
58. Levanon D, Negreanu V, Bernstein Y, et al. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994;23:425-32.
59. Fujita T, Azuma Y, Fukuyama R, et al. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 2004;166:85-95.
60. Yoshida CA, Yamamoto H, Fujita T, et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev 2004;18:952-63.
61. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006;99:1233-9.
62. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002;108:17-29.
63. Varanasi SS, Datta HK. Characterisation of cytosolic FK506 binding protein 12 and its role in modulating expression of Cbfa1 and osterix in ROS 17/2.8 cells. Bone 2005;36:243-53.
64. Liu CJ, Chang E, Yu J, et al. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation. J Biol Chem 2005;280:2788-96.
65. Kang JS, Alliston T, Delston R, et al. Repression of Runx2 function by TGF-b through recruitment of class II histone deacetylases by Smad3. EMBO J 2005;24:2543-55.
66. Komori T. Regulation of skeletal development by the Runx family of transcription factors. J Cell Biochem 2005;95:445-53.
67. Bourgeois P, Stoetzel C, Bolcato-Bellemin AL, et al. The human H-twist gene is located at 7p21 and encodes a b-HLH protein that is 96% similar to its murine M-twist counterpart. Mammalian Genome 1996;7:915-7.
68. Lee MS, Lowe GN, Strong DD, et al. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999;75:566-77.
69. Rice DP, Aberg T, Chan Y, et al. Integration of FGF and TWIST in calvarial bone and suture development. Development 2000;127:1845-55.
70. Bialek P, Kern B, Yang X, et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 2004;6:423-35.
71. Sun XH, Copeland NG, Jenkins NA, et al. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol Cell Biol 1991;11:5603-11.
72. Vinals F, Reiriz J, Ambrosio S, et al. BMP-2 decreases Mash1 stability by increasing Id1 expression. EMBO J 2004;23:3527- 37.
73. Hayashi M, Nimura-K, Kashiwagi-K, et al. Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signalling. J Cell Sci 2007;120:1350-7.
74. Knothe-Tate ML, Adamson JR, Tami AE, et al. The osteocyte. Int J Biochem Cell Biol 2004;36:1-8.
75. Mikuni-Takagaki Y. Mechanical responses and signal transduction pathways in stretched osteocytes. J Bone Miner Metab 1999;17:57- 60.
76. Han Y, Cowin SC, Schaffler MB, et al. Mechano-transduction and strain amplification in osteocyte cell processes. Proc Natl Acad Sci USA 2004;101:16689-94.
77. Holmbeck K, Bianco P, Pidoux I, et al. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 2005;118:147-56.
78. Kamioka H, Honjo T, Takano-Yamamoto T. A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone 2001;28:145-9.
79. Zhao S, Zhang YK, Harris S, et al. MLO-Y4 osteocyte-like cells support osteoclast formation and activation. J Bone Miner Res 2002;17:2068-79.
80. Semb H. Experimental limb disuse and bone blood flow. Acta Orthop Scand 1969;40:552-62.
81. Zerath E. Effects of microgravity on bone and calcium homeostasis. Adv Space Res 1998;21:1049-58
82. Duncan RL, Turner CH. Mechanotransduction and the functional response of bone to mechanical strain. Calcif Tissue Int 1995;57:344-58.
83. Pavalko FM, Norvell SM, Burr DB, et al. A model for mechanotransduction in bone cells: the load-bearing mechanosomes. J Cell Biochem 2003;88:104-12.
84. Tarbell JM, Weinbaum S, Kamm RD. Cellular fluid mechanics and mechanotransduction. Ann Biomed Eng 33:1719-23.
85. Holmbeck K, Bianco P, Caterina J, et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999;99:81-92.
86. Zhang K, Barragan-Adjemian C, Ye L, et al. E11/gp38 selective expression in osteocytes: regulation by mechanical strain and role in dendrite elongation. Mol Cell Biol 2006;26:4539-52.
87. Toyosawa S, Shintani S, Fujiwara T, et al. Dentin matrix protein 1 is predominantly expressed in chicken and rat osteocytes but not in osteoblasts. J Bone Miner Res 2001;16:2017-26.
88. Feng Q, Ward LM, Liu L, et al. Loss of DMP-1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006;38:1310-5.
89. van Bezooijen RL, Roelen BA, Visser A, et al. Sclerostin is an osteocytes expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 2004;199:805-14.
90. Rowe PSN, de Zoysa PA, Dong R, et al. MEPE, a new gene expressed in bone marrow and causing osteomalacia. Genomics 2000;67:54-68.
91. Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the osteoblast/ osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003;278:1998- 2007.
92. Weber GF, Ashkar S, Glimcher MJ, et al. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271:509-12.
93. Jain A, Karadag A, Fohr B, et al. Three SIBLINGS (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement-mediated attack. J Biol Chem 2002;277:13700-8.
94. Karadag A, Fedarko NS, Fisher LW. Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44. Cancer Res 2005;65:11545-52.
95. Gudi S, Huvar I, White C, et al. Rapid activation of Ras by fluid flow is mediated by Galpha(q) and Gbetagamma subunits of heterotrimeric G proteins in human endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:994-1000.
96. Li C, Hu Y, Mayr M, et al. Cyclic strain stress-induced MAP kinase phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem 1999;274:25273-80.
97. Li J, Duncan RL, Burr DB, et al. L-type calcium channels mediate mechanically induced bone formation in vivo. J Bone Miner Res 2002;17:1795-800.
98. Dassouli A, Sulpice JC, Roux S, et al. Stretch-induced inositol trisphosphate and tetrakisphosphate production in rat cardiomyocytes. J Mol Cell Cardiol 1993;25:973-82.
99. Lavandero S, Cartagena G, Guarda E, et al. Changes in cyclic AMP dependent protein kinase and active stiffness in the rat volume overload model of heart hypertrophy. Cardiovasc Res 1993;27:1634- 8.
100. Hughes DE, Salter, DM, Dedhar S, et al. Integrin expression in human bone. J Bone Miner Res 1993;8:527-33.
101. Kapur S, Baylink DJ, William Lau KH. Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 2003;32:241-51.
102. Ishida T, Peterson TE, Kovach NL, et al. MAP kinase activation by flow in endothelial cells. Role of beta 1 integrins and tyrosine kinases. Circ Res 1996;79:310-6.
103. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999;71:435-78.
104. Alford AI, Jacobs CR, Donahue HJ. Oscillating fluid flow regulates gap junction communication in osteocytic MLO-Y4 cells by an ERK1/2 MAP kinase-dependent mechanism. Bone 2003;33:64-70.
105. Smalt R, Mitchell FT, Howard RL, et al. Mechanotransduction in bone cells: induction of nitric oxide and prostaglandin synthesis by fluid shear stress, but not by mechanical strain. Adv Exp Med Biol 1997;433:311-4.
106. Klein RF, Allard J, Avnur Z, et al. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 2004;303:229-32.
107. Takahashi N, Akatsu T, Udagawa N, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988;123: 2600-2.
108. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
109. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.
110. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990;87:4828- 32.
111. Yoshida H, Hayashi S, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-4.
112. Cella M, Buonsanti C, Strader C, et al. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med 2003;198:645-51.
113. Paloneva J, Mandelin J, Kiialainen A, et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 2003;198:669.
114. Kim N, Takami M, Rho J, et al. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med 2002;195:201-9.
115. Ishikawa S, Noriko Arase N, Suenaga T, et al. Involvement of FcRγ in signal transduction of osteoclast-associated receptor (OSCAR) fusion. Int Immunol 2004;16:1019-25.
116. Koga T, Inui M, Inoue K, et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 2004;428:758-63.
117. Mocsai A, Humphrey MB, Van Ziffle JA, et al. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc Natl Acad Sci USA 2004;101:6158-63.
118. Mao D, Epple H, Uthgenannt B, et al. PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest 2006;116:2869-79.
119. Gohda J, Akiyama T, Koya T, et al. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J 2005;24:790-9.
120. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002;109:67-79.
121. Takayanagi H, Kim S, Koya T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling for terminal differentiation of osteoclasts. Dev Cell 2002;3:889-901.
122. Ikeda F, Nishimura R, Matsubara T, et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 2004;114:475-84.
123. Asagiri M, Sato K, Usami T, et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005;202:1261-9.
124. Zhao Q, Shao J, Chen W, et al. Osteoclast differentiation and gene regulation. Front Biosci 2007;12:2519-29.
125. 2+]; oscillation regulation. Genes Dev 2007;21:1803-16.
126. Davies J. Warwick J, Totty N, et al. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989;109:1817-26.
127. Shankar G, Davison I, Helfrich MH, et al. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts. J Cell Science 1993;105:61-8.
128. Datta HK. Manning P, Rathod H, et al. Effect of calcitonin, elevated calcium and extracellular matrix osteoclasts matrices on superoxide anion production by rat osteoclast. Exp Physiol 1995;80:713-9.
129. Nakamura I, Jimi E, Duong LT, et al. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts. J Biol Chem 1998;273:11144-9.
130. Teti A, Marchisio PC, Zambonin-Zallone A. Clear zone in osteoclast function: role of podosomes in regulation of bone-resorbing activity. Am J Physiol 1991;261:C1-C7
131. Soriano P, Montgomery C, Geske R, et al. Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell 1991;64:693-702.
132. Sanjay A, Houghton A, Neff L, et al. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v)beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 2001;152:181-95.
133. Chellaiah MA, Soga N, Swanson S, et al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000;275:11993-2002.
134. Oda A, Ochs HD, Lasky LA, et al. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood 2001;97:2633-9.
135. Kolluri R, Tolias KF, Carpenter CL, et al. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc Natl Acad Sci USA 1996;93:5615-8.
136. Calle V, Jones GE, Jagger C, et al. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 2004;103:3552-61.
137. Chellaiah MA, Kuppuswamy D, Lasky L, et al. Phosphorylation of a WASP-associated signal complex is critical in osteoclast bone resorption. J Biol Chem 2007;282:10104-16.
138. Nesbitt SA, Horton MA. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997;276:266-9.
139. Salo J, Lehenkari P, Mulari M, et al. Removal of osteoclast bone resorption products by transcytosis. Science 1997;276:270-3.
140. Berger CE, Rathod H, Gillespie JI, et al. Scanning electrochemical microscopy at the surface of bone-resorbing osteoclasts: evidence for steady-state disposal and intracellular functional compartmentalization of calcium. J Bone Miner Res 2001;16:2092- 102.
141. Datta HK, Horrocks BR. Mechanisms of calcium disposal from osteoclastic resorption hemivacuole. J Endocrinol 2003;176:1-5.
142. 2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption. Endocrinology 2007;148:2116-25.
143. Ito M, Haito S, Furumoto M, et al. Unique uptake and efflux systems of inorganic phosphate in osteoclast-like cells. Am J Physiol 2007;292:C526-34.
144. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-9.
145. Kotake S, Udagawa N, Harkada M, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001;44:1003-12.
146. Cenci S, Toraldo G, Weirzmann MN, et al. Estrogen deficiency induces bone loss by enhancing T cell production of TNF-α. J Clin Invest 2000;106:1229-37.
147. Grčević D, Lukić IK, Kovačić N, et al. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos. Clin Exp Immunol 2006;146:146-58.
148. Dai SM, Nishioka K, Yudoh K. Interieukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1β and tumour necrosis factor α. Ann Rheum Dis 2004;63:1379-86.
149. Gillespie MT. Commentary: Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res Ther 2007;9:103-5.
150. Yun TJ, Chaudhary PM, Shu GL, et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 1998;161:6113-21.
151. Choi Y, Kim JJ. B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. Exp Mol Med 2003;35:385-92.
152. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9.
153. Li Y, Toraldo G, Li S, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 2007;109:3839-48.
154. Chapoval AI, Ni J, Lau JS, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-g production. Nat Immunol 2001;2:269-74.
155. Zang X, Loke P, Kim J, et al. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003;100:10388-92.
156. Stashenko P, Dewhirst FE, Peros WJ, et al. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987;138:1464-8.
157. Ragab AA, Nalepka JL, Bi Y, et al. Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol 2002;283:C679-87.
158. Lam J, Takeshita S, Barker JE, et al. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000;106:1481-8.
159. Kim N, Kadono Y, Takami M, et al. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med 2005;202:589-95.
160. Jimi E, Nakamura I, Ikebe T, et al. Activation of NF-kappaB is involved in the survival of osteoclasts promoted by interleukin-1. J Biol Chem 1998;273:8799-805.
161. Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev 1997;8:253-65.
162. Holt I, Davie MW, Marshall MJ. Osteoclasts are not the main source of interleukin-6 in mouse parietal bone. Bone 1996;18:221-6.
163. Udagawa N, Takahashi N, Katagiri T, et al. Interieukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 1995;182:1461-8.
164. Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
165. Moreno JL, Kaczmarek M, Keegan AD, et al. IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL. Blood 2003;102:1078-86.
166. Kim YG, Lee CK, Nah SS, et al. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 2007;357:1046-52.
167. Takayanagi H, Kim S, Matsuo K, et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 2002;416:744-9.
168. Mauro U, Olmsted EA, Skrobacz BM, et al. Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular differentiation. J Biol Chem 1994;269:30659-67.
169. Lee NK, Sowa, H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-69.